|
|
|
|
|
GlaxoSmithKline Selects Retail Supplier Affiliate To Assist With Fleet Electrification
January 28, 2022
Email This Story
Copyright 2010-21 EnergyChoiceMatters.com
Reporting by Paul Ring • ring@energychoicematters.com
The following story is brought free of charge to readers by EC Infosystems, the exclusive EDI provider of EnergyChoiceMatters.com
ARI, a global fleet management provider specializing in complex car and truck fleets, and Enel X, the advanced energy services arm of the Enel Group, announced that they will collaborate with GlaxoSmithKline (GSK) to transition the healthcare company's North American fleet to 100 percent electric vehicles (EVs) by 2030.
Through the pilot project, part of GSK's commitment to the EV100 initiative, ARI, a division of Holman, and Enel will help GSK implement a holistic sustainability solution that includes the deployment of electric and hybrid plug-in vehicles and installation of more than 100 charging locations.
Together, ARI and Enel X, with installation support from Qmerit, are providing GSK with a turnkey fleet management and sustainability solution. The initiative began with an analysis of historical and real-time fleet data, allowing ARI and GSK to prioritize the vehicles and drivers ideally suited to transition to EV units. ARI is also facilitating the ordering and delivery of the electric and hybrid plug-in vehicles to align with the strategic charging applications provided by Enel X.
The scope of the infrastructure project includes JuiceBox smart charging stations and JuiceNetFleet IoT software to help effectively manage the electric vehicle fleet
Enel X has deployed approximately 230,000 charging ports worldwide and said that it is the preferred energy services provider for more than 10,000 organizations at 35,000 locations across the globe
ADVERTISEMENT
NEW Jobs on RetailEnergyJobs.com:
• NEW! -- Energy Pricing Analyst -- Retail Supplier
• NEW! -- Digital Marketing Manager -- Energy Marketer
Copyright 2010-21 Energy Choice Matters. If you wish to share this story, please email or post the website link; unauthorized copying, retransmission, or republication prohibited.
|
|
|
|